<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04721080</url>
  </required_header>
  <id_info>
    <org_study_id>IKC145</org_study_id>
    <nct_id>NCT04721080</nct_id>
  </id_info>
  <brief_title>Pulmonary Tuberculosis Sequelae in Patients With COPD</brief_title>
  <official_title>Effects of Pulmonary Tuberculosis Sequelae on Functional Outcomes in Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Izmir Katip Celebi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Izmir Katip Celebi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is known that there is a complex relationship between tuberculosis and COPD.&#xD;
      Post-tuberculosis airway disease or COPD associated with tuberculosis occurs in a significant&#xD;
      portion of tuberculosis patients. However, it was observed that mortality rates and&#xD;
      exacerbation rates of COPD patients with tuberculosis sequel were higher. However, the effect&#xD;
      of tuberculosis sequela on functional outcomes in COPD patients has not been investigated in&#xD;
      the studies.&#xD;
&#xD;
      The aim of this study is to determine whether the previous tuberculosis sequelae has a&#xD;
      functional effect on patients with COPD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research is planned as a cross-sectional study. It will start within one week following&#xD;
      the approval of the ethics committee and will be completed within one year. The universe of&#xD;
      the study is S.B.Ü. Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital&#xD;
      consists of patients who apply to Pulmonary Rehabilitation Outpatient Clinic. Participants&#xD;
      will consist of two different groups: COPD patients with tuberculosis and COPD patients&#xD;
      without tuberculosis. The voluntary principle will be taken into account in participating in&#xD;
      the research.&#xD;
&#xD;
      Within the scope of the evaluation; Demographic and clinical information of the people who&#xD;
      will participate in the study will be recorded, and Thorax CT and PFT examinations performed&#xD;
      within the polyclinic service within the last 1 month will be evaluated. Saint George&#xD;
      Respiratory Questionaire (SGRQ), 6-minute walk test (6MWT), Medical Research Council Dyspnea&#xD;
      Scale (MRC), COPD assessment test (CAT) will be applied to the patients. Regarding the&#xD;
      illness histories, the number of hospitalizations and emergency admissions in the last 1 year&#xD;
      will be recorded. Detailed tuberculosis anamneses will also be taken from patients with&#xD;
      tuberculosis sequelae.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Exercise Capacity</measure>
    <time_frame>6 minutes- baseline</time_frame>
    <description>Six minutes walk test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnea Assessment</measure>
    <time_frame>5 minutes- baseline</time_frame>
    <description>Medical Research Council Scale(MRC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COPD Assessment</measure>
    <time_frame>5 minutes- baseline</time_frame>
    <description>COPD Assessment Test (CAT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Assessment</measure>
    <time_frame>20 minutes- baseline</time_frame>
    <description>St. George Respiratory Questionaire</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Copd</condition>
  <condition>Tuberculosis</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>COPD patients with tuberculous sequelae</arm_group_label>
    <description>COPD patients with tuberculous sequelae</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD patients without tuberculosis sequela</arm_group_label>
    <description>COPD patients with tuberculous sequelae</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional Outcome Measurements</intervention_name>
    <description>Dyspnea Exercise capacity Quality of life assessment</description>
    <arm_group_label>COPD patients with tuberculous sequelae</arm_group_label>
    <arm_group_label>COPD patients without tuberculosis sequela</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients with tuberculous sequelae and COPD patients without tuberculosis sequela&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Volunteering to participate in the study&#xD;
&#xD;
          -  Being over 18 years old&#xD;
&#xD;
          -  Having thorax CT in the last 1 month&#xD;
&#xD;
          -  Having PFT examination performed in the last 1 month&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Being in a COPD attack&#xD;
&#xD;
          -  The patient has additional pulmonary comorbidity such as Lung Ca, bronchiectasis, lung&#xD;
             fibrosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hulya Sahin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>İlknur N Gürşan, Assoc Prof</last_name>
    <phone>05356954634</phone>
    <email>ilknurnaz4@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>İlknur Naz Gürşan</name>
      <address>
        <city>İzmir</city>
        <zip>35620</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>İlknur N Gürşan</last_name>
      <phone>05356954634</phone>
      <email>ilknurnaz4@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hulya Sahin, Assoc Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>February 27, 2021</last_update_submitted>
  <last_update_submitted_qc>February 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Izmir Katip Celebi University</investigator_affiliation>
    <investigator_full_name>Ilknur Naz</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>copd</keyword>
  <keyword>tuberculosis</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

